Spinal cord injury study
Part of Brain & nervous system, Injuries & trauma clinical trials.
This study looks at people with spinal cord injuries to understand common problems and how to manage them. It may help improve care for people with paraplegia or tetraplegia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with paraplegia (paralysis of the lower half of your body)
- You have been diagnosed with tetraplegia (paralysis of both arms and legs)
- You do not have a traumatic brain injury, brain tumor, or other brain lesions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial collects tissue samples from people with new spinal cord injuries to study recovery. It may help researchers understand how to improve treatment.
This study looks for ways to test treatments for people with spinal cord injuries and/or brain injuries. It may help researchers better understand which treatment approaches work and for whom.
This study looks at medical and legal aspects of recent spinal cord injuries. They are collecting information from patients like you to understand the injury and its effects.
This study looks at how people recover and rehabilitate after a spinal cord injury, which may help improve future rehabilitation programs.
This trial is a registry that collects information about people 18 and older who have a first spinal cord injury caused by trauma. By sharing details, you help researchers better understand outcomes and care needs after these injuries.
This study is for people who have had a sudden spinal cord injury from trauma or a sudden lack of blood flow (ischemia) and can be assessed within six weeks. It aims to better understand spinal cord injury and may help guide future care.
Hear when a new Spinal Cord Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.